| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326766 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
Despite CA-125 AUC high correlation with the FIGO stage, residual disease, and patient final outcome, the main interest of CA-125 AUC calculation is to evaluate the treatment efficacy and to foresee a full chemotherapy response. Further studies should be carried out before extrapolating these results to other data sets.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
A. Mano, A. Falcão, I. Godinho, J. Santos, F. Leitão, C. Oliveira, M. Caramona,